Human trials of oral drug underway to test effectiveness against Covid-19 – Hindustan Times

An orally-administered antiviral drug initially developed to treat influenza can significantly decrease novel coronavirus levels in hamsters and is in the final stages of human trials, holding out promise of a pill to combat Covid-19, say researchers.
Scientists from the National Institutes of Health (NIH) in the US and the University of Plymouth in the UK found that MK-4482, also called Molnupiravir, was effective when provided up to 12 hours before or 12 hours after infection with SARS-CoV-2,…

Click here to view the original article.